Press Release
Category Added in a WPeMatico Campaign
-
Chestnut Carbon Becomes First U.S. IFM Project Verified for Biodiversity Conservation Impacts with Forest Stewardship Council ®
NEW YORK, Feb. 10, 2026 /PRNewswire/ — Chestnut Carbon (“Chestnut”), a leading U.S. developer of nature-based carbon removal projects, today announced…
Read More » -
North Stars Shine Bright at ETA Conference
Sales, Compliance, and Product professionals honored at TRANSACT 2026 TROY, Mich., Feb. 10, 2026 /PRNewswire/ — North, a U.S.-based leader…
Read More » -
EVOLV CONSULTING ANNOUNCES MIRAIN CHILTON AS CHIEF FINANCIAL OFFICER
evolv Consulting: Reinforcing Commitment to Talent Development and Organizational Excellence DALLAS, Feb. 10, 2026 /PRNewswire/ — evolv Consulting announced that Mirain Chilton…
Read More » -
Coveo Announces Hosted MCP Server to Expand Enterprise AI and Agentic Partner Ecosystem
New interoperability layer for secure AI access to enterprise content connects Coveo to leading large language models, including ChatGPT Enterprise…
Read More » -
Natilus Unveils New Enhancements to its Hyper-Efficient HORIZON EVO Passenger Aircraft as it Readies For FAA Certification and Commercial Fleet Integration
Critical feedback from FAA and carrier customers addresses certification requirements Design includes new dual-deck cabin, improved egress, and faster turnaround…
Read More » -
ECOVACS Launches GOAT PRO LiDAR Series with First-ever Built-in AI Edge Trimmer, Its Most Complete Autonomous Lawn Care Solution Yet – Available Now
SAN MATEO, Calif., Feb. 10, 2026 /PRNewswire/ — ECOVACS, a global pioneer in intelligent home robotics, announces the availability of…
Read More » -
Ceva Wi-Fi 6 and Bluetooth IPs Power Renesas’ First Combo MCUs for IoT and Connected Home
Ceva-Waves Connectivity IPs Enable Renesas to Deliver Flexible, Power-Efficient Wireless Solutions for Next-Generation IoT Systems ROCKVILLE, Md., Feb. 10, 2026…
Read More » -
New REZOLVE-AD Maintenance Data in Atopic Dermatitis Demonstrate Rezpegaldesleukin Resulted in Durable and New Responses Across Key Disease Measurements with Both Monthly and Quarterly Dosing
71% and 83% of patients maintained EASI-75 responses and 85% and 63% maintained vIGA-AD 0/1 responses with 24 µg/kg monthly and…
Read More »
